Green Tea Extracts for Mild-to-moderate Diabetic Peripheral Neuropathy

the present randomized placebo-controlled study aimed to evaluate the effect of green tea extract administration on the clinical and neurophysiological parameters in patients with mild-to-moderate diabetic peripheral neuropathy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetic Peripheral Neuropathy

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Al-Azhar University Faculty of Medicine

Cairo, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diabetic patients with peripheral neuropathy

Exclusion criteria

Patients under treatment of diabetic peripheral neuropathy.
Patients with other causes of peripheral neuropathy.

Treatment and study plan

Green Tea

Dietary Supplement

Green tea extract capsules

Placebo

Other

Placebo containing inert material.

Primary outcomes

Toronto Clinical Scoring System

Time frame: three months

Improvement describes the difference between baseline and post-intervention outcome parameters

Sponsors and collaborators

Lead sponsor

Egyptian Biomedical Research Network

Network

Registry information

Official study title

Green Tea Extracts for Mild-to-moderate Diabetic Peripheral Neuropathy A Randomized Controlled Trial

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Sep 10, 2020
Registry last updated: Sep 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed